Quarterly Report · 10-Q
FF EAI Robotics Ecosystem Inc.
Quarterly Report
Company context
We are an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. Our business now consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program (Pan-RAS).
Current securities
Historical securities (1)
Recent company filings
- Regulation FD DisclosureOct 26, 2026
- Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets · Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Regulation FD DisclosureOct 26, 2026
- Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Regulation FD DisclosureOct 14, 2026
- Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Regulation FD DisclosureSep 29, 2026
- Other EventsSep 29, 2026
Document unavailable
This filing is not currently available in the archive. Read it on SEC EDGAR ↗